PRMT5 and B-cell chronic lymphocytic leukemia: Upon this observation, we next evaluated the PRMT5 protein expression in CLL cells from the blood of patients that eventually did (CLL pre-RT) or did not (CLL) transform to RT within one year from the time the sample was collected.